Starting with Seed Train: A Process Intensification Success Story
The rising costs and global demand of biologics is putting pressure on the biopharmaceutical industry to pursue rapid and cost-effective development strategies. In upstream bioprocessing, seed train intensification provides an effective solution that can be adapted relatively easily to existing processes.
This webinar presents how Intas Pharmaceutical, a leading biosimilars product manufacturer, targeted seed train intensification as a viable entry point to explore intensified manufacturing using single-use rocking motion (RM) technology.
Discover the value of seed train intensification in manufacturing scenarios.
Learn about the various approaches that can be taken to intensify the seed train.
Review how a biosimilars manufacturer developed a successful seed train intensification approach.
Explore the main challenges that can be faced when implementing an N-1 perfusion process.
Meet Our Experts
Rajib Malla
Assistant General Manager at Intas Pharmaceuticals
Rajib Malla has been leading the Microbial & Mammalian MSAT Team since 2017 at Intas Pharma. He works with multiple complex customer-facing product project teams using a standard methodology to evaluate new technologies and to successfully transfer existing technologies into cGMP biologics.
Priyanka Gupta
Head of External Collaborations, Separations Technology
Priyanka Gupta is the Head of External Collaborations for Separation Technologies at Sartorius. Priyanka has almost 20 years of experience in process development. Her experience managing process modeling activities has afforded her a deep understanding of the economic impact of implementing Process Intensification for various modalities and scales.